SCHEMBL23064635

SCHEMBL23064635

C=C(C)OC(=O)N1CCCC1c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 4/20 0.58
HSP90AA1 P07900 1/20 0.51
HSP90AB1 P08238 1/20 0.51
CHRNB2 P17787 1/20 0.46
CHRNB4 P30926 1/20 0.46
CHRNA3 P32297 1/20 0.46
CHRNA7 P36544 1/20 0.46
CHRNA4 P43681 1/20 0.46
EPHX2 P34913 2/20 0.46
HSD11B1 P28845 2/20 0.46
SCD5 Q86SK9 4/20 0.45
SCD O00767 3/20 0.45
CCNC P24863 1/20 0.44
CDK8 P49336 1/20 0.44
HSD17B10 Q99714 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12650282 0.86 CCNC (0.43) RIPK1HSP90AA1HSP90AB1CHRNB2CHRNA7
SCHEMBL10002512 0.82 RIPK1 (0.64) RIPK1HSP90AA1HSP90AB1CHRNB2CHRNB4
SCHEMBL19217206 0.81 RIPK1 (0.62) RIPK1HSP90AA1HSP90AB1CHRNB2CHRNB4
SCHEMBL8275419 0.81 RIPK1 (0.69) RIPK1HSP90AA1HSP90AB1CHRNB2CHRNB4
SCHEMBL17454944 0.81 RIPK1 (0.69) RIPK1HSP90AA1HSP90AB1CHRNB2CHRNB4
SCHEMBL22322395 0.80 DPP4 (0.40) RIPK1
SCHEMBL6960066 0.80 RIPK1 (0.69) RIPK1HSP90AA1HSP90AB1CHRNB2CHRNB4
SCHEMBL18642714 0.80 RIPK1 (0.69) RIPK1HSP90AA1HSP90AB1CHRNB2CHRNB4
SCHEMBL23064515 0.79 RIPK1 (0.59) RIPK1HSP90AA1HSP90AB1CHRNB2CHRNB4
SCHEMBL20178113 0.79 RIPK1 (0.59) RIPK1HSP90AA1HSP90AB1CHRNB2CHRNB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024140678-A1 A KETAL PROTECTED INTERMEDIATE FOR SONROTOCLAX AND PREPARATION METHOD THEREOF BEIGENE (SUZHOU) CO., LTD. (CN) 2024-07-04 WO disclosed
WO-2024017354-A1 METHODS OF TREATING MULTIPLE MYELOMA USING BCL-2 INHIBITOR BEIGENE, LTD. (KY) 2024-01-25 WO disclosed
WO-2021110102-A1 METHODS OF CANCER TREATMENT USING BCL-2 INHIBITOR BEIGENE, LTD. (KY) 2021-06-10 WO disclosed
WO-2021083135-A1 Bcl-2 INHIBITORS BEIGENE, LTD. (KY) 2021-05-06 WO disclosed
EP-3788042-A1 BCL-2 INHIBITORS BeiGene, Ltd. (KY) 2021-03-10 EP disclosed